1. Home
  2. Analysis
  3. Zolpidem
  4. Autoimmune-hepatitis

Zolpidem and Autoimmune hepatitis - a phase IV clinical study of FDA data

Summary:

Autoimmune hepatitis is reported as a side effect among people who take Zolpidem (zolpidem tartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Escitalopram, and have Depression.

The phase IV clinical study analyzes which people have Autoimmune hepatitis when taking Zolpidem. It is created by eHealthMe based on reports of 90,339 people who have side effects when taking Zolpidem from the FDA, and is updated regularly.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,696 Zolpidem users. Check the latest studies of Zolpidem.

What is Autoimmune hepatitis?

Autoimmune hepatitis is found to be associated with 580 drugs and 820 conditions by eHealthMe. Check the latest studies of Autoimmune hepatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

90,339 people reported to have side effects when taking Zolpidem.
Among them, 29 people (0.03%) have Autoimmune hepatitis.

Could Zolpidem cause Autoimmune hepatitis?

Among these 29 people:

How long have people been on Zolpidem when they have Autoimmune hepatitis? *

  • < 1 month: 85.71 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Autoimmune hepatitis when taking Zolpidem? *

  • female: 84 %
  • male: 16 %

What is the age of people who have Autoimmune hepatitis when taking Zolpidem? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4 %
  • 30-39: 8 %
  • 40-49: 4 %
  • 50-59: 12 %
  • 60+: 72 %

What are other drugs people take besides Zolpidem? *

  1. Escitalopram: 11 people, 37.93%
  2. Calcium: 4 people, 13.79%
  3. Vitamin D3: 4 people, 13.79%
  4. Zometa: 2 people, 6.90%
  5. Ambien: 2 people, 6.90%
  6. Prednisolone: 2 people, 6.90%
  7. Zyban: 1 person, 3.45%
  8. Duloxetine Hydrochloride: 1 person, 3.45%
  9. Lipitor: 1 person, 3.45%
  10. Lenalidomide: 1 person, 3.45%

What are other side effects people have besides Autoimmune hepatitis? *

  1. Alanine Aminotransferase Increased: 6 people, 20.69%
  2. Aspartate Aminotransferase Increased: 6 people, 20.69%
  3. Hepatic Necrosis (large portions of liver die off due to severe liver disease): 5 people, 17.24%
  4. Hepatomegaly (abnormal enlargement of the liver): 3 people, 10.34%
  5. Blood Lactate Dehydrogenase Increased: 3 people, 10.34%
  6. Blood Creatine Phosphokinase Increased: 3 people, 10.34%
  7. Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 3 people, 10.34%
  8. Liver Function Test Abnormal: 2 people, 6.90%
  9. Blood Bilirubin Increased: 2 people, 6.90%
  10. Hepatic Fibrosis (scarring process that represents the liver's response to injury): 2 people, 6.90%

What are the existing conditions these people have? *

  1. Depression: 13 people, 44.83%
  2. Malignant Melanoma (skin cancer rises from melancytes): 5 people, 17.24%
  3. Metastases To Bone (cancer spreads to bone): 4 people, 13.79%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 6.90%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.90%
  6. Stress And Anxiety: 1 person, 3.45%
  7. Dyslipidaemia (abnormal amount of lipids): 1 person, 3.45%
  8. Gastritis (inflammation of stomach): 1 person, 3.45%
  9. Gastric Disorder (disease of stomach): 1 person, 3.45%
  10. Fatigue (feeling of tiredness): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Zolpidem and have Autoimmune hepatitis?

- Check whether Autoimmune hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zolpidem:

Autoimmune hepatitis treatments and more:

How severe was Autoimmune hepatitis and when was it recovered:

Expand to all the drugs that have ingredients of zolpidem tartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Autoimmune hepatitis:

Browse all the conditions that are associated with Autoimmune hepatitis:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Zolpidem) and Zolpidem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.